PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2023; 27(01): e111-e116
DOI: 10.1055/s-0042-1744168
Original Research

Comparative Analysis of the Quality of Life in the Pretreatment of Head and Neck Cancer Patients According to Tumor Site

Autor*innen

  • Marla S. P. Cruz 

    1   Departament of Public Health/Epidemiology, Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil

  • Tercio G. Reis 

    2   High Complexity Unit in Oncology of Feira de Santana, Feira de Santana, Bahia, Brazil

  • Jackeline Sena Nunes 

    3   Departament of Health, Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil

  • Antoniel C. Oliveira 

    4   Núcleo de Pesquisa em Câncer de Cabeça e Pescoço (NUPESCAP), Feira de Santana, Bahia Brazil

  • Ágda Braga Teixeira 

    3   Departament of Health, Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil

  • Karina Silva Costa 

    3   Departament of Health, Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil

  • Márcio C. Oliveira 

    1   Departament of Public Health/Epidemiology, Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Introduction Head and neck cancer (HNC) and its treatment can cause physical, psychological, and quality of life (QoL) damage, because it can disturb the physiology of eating, breathing, speaking, and compromise self-image.

Objective To evaluate the QoL of the pretreatment of patients diagnosed with head and neck cancer according to the anatomical location of the tumor.

Methods A descriptive, cross-sectional study was performed on a sample of 144 patients undergoing pretreatment for cancer from February 2017 to July 2019. The University of Washington QoL Questionnaire (version 4) was used to assess the QoL. The anatomical location data were obtained from medical records. The ANOVA test was used to compare the differences in QoL according to tumor location.

Results A total of 144 participants were included, 66 (45.5%) of whom had the primary tumor located in the mouth. The median age of the patients was 62 years, with a higher prevalence of male (75.7%), Black (78.5%), single/divorced/widowed people (59%), and illiterates (32.6%); most of them were smokers (84.7%) and alcohol drinkers (79.2%). The mean QoL score was 830 for mouth cancer, 858 for pharynx cancer, and 891 for laryngeal cancer patients.

Conclusion Based on the results of this study, it can be concluded that the QoL of patients with head and neck cancer was not influenced by tumor location. The most affected domains in the three groups were pain, appearance, chewing, swallowing, and speech (p < 0.05).

Keywords

quality of life - head and neck cancer - mouth cancer - laryngeal cancer - pharyngeal neoplasms


Publikationsverlauf

Eingereicht: 28. August 2021

Angenommen: 24. Januar 2022

Artikel online veröffentlicht:
01. August 2022

© 2023. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil